HopeStage
Back to all studies
CompletedNCT02832401

Caffeine and Thinking Skills in People With Schizophrenia

About this titleRead the official source — NCT02832401
Medication studyAges 18–35Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 35 years.

Listed locations
HalifaxSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 2, 2016
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
Nova Scotia Health Authority
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Locations
Canada
Age range
From 18 Years to 35 Years
Official registry ID
NCT02832401
Official title
Show the full official title

The Impact of Caffeine on Cognition in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Halifax

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Nova Scotia Health Authority.

Did this study involve medication?

Yes. The study involved medication, including Caffeine and Placebo.

Who was this study for?

Listed age limits: 18 years to 35 years.

Want to explore more studies?

Explore studies